ALAMAB THERAPEUTICS
Princeton
About ALAMAB THERAPEUTICS
AlaMab provides antibody drugs. They also provide commercializing novel monoclonal antibody therapeutics to benefit patients suffering from indications with significant unmet treatment needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $11.8M
- Last round: Series Unknown (Aug 2017)
- Website: alamab.com
- Phone: +1 609-356-0210
Industries & Categories
Biotechnology, Medical, Therapeutics
Canonical: https://fsome.com/organization/alamab-therapeutics-146222 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.